Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma
New England Journal of Medicine · 17.10.2024 · 391 (15) · 1379-1389
DOI: 10.1056/nejmoa2405888 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift New England Journal of Medicine, erschienen am 17.10.2024. Verfasst von Alex F Herrera und 46 weiteren Autor:innen. Beteiligte Einrichtung: From City of Hope Comprehensive Cancer Center, Duarte (A.F.H., M.G.M., J.Y.S.), University of California Davis Comprehensive Cancer Center, Sacrament…. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Brentuximab Vedotin, Dacarbazine, Doxorubicin. Die Arbeit wurde bisher 279-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, SeaGen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From City of Hope Comprehensive Cancer Center, Duarte (A.F.H., M.G.M., J.Y.S.), University of California Davis Comprehensive Cancer Center, Sacramento (J.M.T.), and Children's Hospital Los Angeles, Los Angeles (C.F., A.…
ORCID-Profile: Alex F Herrera, Sharon M Castellino, Andrew M Evens, Boyu Hu
Förderung
- NCI NIH HHS
- NIH HHS
- SeaGen
- Bristol-Myers Squibb
- National Cancer Institute, National Institutes of Health
Zitieren
APA
Herrera, A. F., LeBlanc, M., Castellino, S. M., Li, H., Rutherford, S. C., Evens, A. M., Davison, K., Punnett, A., Parsons, S. K., Ahmed, S., Casulo, C., Bartlett, N. L., Tuscano, J. M., Mei, M. G., Hess, B. T., Jacobs, R., Saeed, H., Torka, P., Hu, B., …, & Friedberg, J. W. (2024). Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma. New England Journal of Medicine, 391(15), 1379-1389. https://doi.org/10.1056/nejmoa2405888
Vancouver
Herrera AF, LeBlanc M, Castellino SM, Li H, Rutherford SC, Evens AM, et al. Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma. New England Journal of Medicine. 2024;391(15):1379-1389. doi:10.1056/nejmoa2405888
BibTeX
@article{Herrera2024,
author = {Herrera, Alex F and LeBlanc, Michael and Castellino, Sharon M and Li, Hongli and Rutherford, Sarah C and Evens, Andrew M and Davison, Kelly and Punnett, Angela and Parsons, Susan K and Ahmed, Sairah and Casulo, Carla and Bartlett, Nancy L and Tuscano, Joseph M and Mei, Matthew G and Hess, Brian T and Jacobs, Ryan and Saeed, Hayder and Torka, Pallawi and Hu, Boyu and Moskowitz, Craig and Kaur, Supreet and Goyal, Gaurav and Forlenza, Christopher and Doan, Andrew and Lamble, Adam and Kumar, Pankaj and Chowdhury, Saeeda and Brinker, Brett and Sharma, Namita and Singh, Avina and Blum, Kristie A and Perry, Anamarija M and Kovach, Alexandra E and Hodgson, David and Constine, Louis S and Shields, Lale Kostakoglu and Prica, Anca and Dillon, Hildy and Little, Richard F and Shipp, Margaret A and Crump, Michael and Kahl, Brad and Leonard, John P and Smith, Sonali M and Song, Joo Y and Kelly, Kara M and Friedberg, Jonathan W},
title = {Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma},
journal = {New England Journal of Medicine},
year = {2024},
volume = {391},
number = {15},
pages = {1379--1389},
doi = {10.1056/nejmoa2405888}
}
EUVIMED